Dengue virus (DENV) is the leading cause of mosquito-borne viral illness and death in humans. Like many viruses, DENV has evolved potent mechanisms that abolish the antiviral response within infected cells. Nevertheless, several in vivo studies have demonstrated a key role of the innate immune response in controlling DENV infection and disease progression. Here, we report that sensing of DENV infected cells by plasmacytoid dendritic cells (pDCs) triggers a robust TLR7-dependent production of IFNa, concomitant with additional antiviral responses, including inflammatory cytokine secretion and pDC maturation. We demonstrate that unlike the efficient cell-free transmission of viral infectivity, pDC activation depends on cell-to-cell contact, a feature observed for various cell types and primary cells infected by DENV, as well as West Nile virus, another member of the Flavivirus genus. We show that the sensing of DENV infected cells by pDCs requires viral envelope protein-dependent secretion and transmission of viral RNA. Consistently with the cell-to-cell sensing-dependent pDC activation, we found that DENV structural components are clustered at the interface between pDCs and infected cells. The actin cytoskeleton is pivotal for both this clustering at the contacts and pDC activation, suggesting that this structural network likely contributes to the transmission of viral components to the pDCs. Due to an evolutionarily conserved suboptimal cleavage of the precursor membrane protein (prM), DENV infected cells release uncleaved prM containingimmature particles, which are deficient for membrane fusion function. We demonstrate that cells releasing immature particles trigger pDC IFN response more potently than cells producing fusion-competent mature virus. Altogether, our results imply that immature particles, as a carrier to endolysosome-localized TLR7 sensor, may contribute to regulate the progression of dengue disease by eliciting a strong innate response.
Introduction
The innate immune system acts as the first line of defense for the sensing of viral infection. This involves rapid recognition of pathogen-associated molecular patterns (PAMPs), including viral nucleic acids, by pattern recognition receptors (PRRs). This recognition results in an antiviral response characterized by the production of type I interferons (IFNs) and expression of IFNstimulated genes (ISGs). This response suppresses viral spread by blocking the viral life cycle at multiple levels and also mediates immunomodulatory effects in surrounding tissues that impart the onset of the adaptive immune response [1] . The PRR can be cytoplasmic, e.g., retinoic inducible gene-I (RIG-I)-like receptors (RLRs) and NOD-like receptors (NLRs), or endosomal, e.g., Toll-like receptors (TLRs) [1] . Thus, depending on their intracellular localization, virus-induced innate immune signaling typically occurs within cells that are either productively infected or that have internalized viral particles [1, 2] .
Recent studies illustrated the existence of alternative host sensing strategies by bystander plasmacytoid dendritic cells (pDCs), which recognize infected cells [3, 4, 5, 6, 7] . pDCs are immune cells known to function as sentinels of viral infection and are a major type I IFN-producing cell type in vivo [8, 9] . Using hepatitis C virus (HCV) as a model, we recently demonstrated that HCV infected cells can selectively package immunostimulatory viral RNA within exosomes that deliver their RNA cargo to pDCs, which, in turn, produce IFNa [3] . Exosomes also permit transfer to pDCs of distinct immunostimulatory viral RNAs, such as those of the negative strand lymphocytic choriomeningitis virus (LCMV) [4] . This sensing pathway is thought to assure recognition of infected cells and hence protects the host against viruses that defeat the pathogen-sensing machinery within the cells they infect.
Virtually all viruses have evolved strategies that preclude antiviral signaling in the cell they infect [10] . For example, dengue virus (DENV) has evolved several evasion strategies that prevent IFN and ISG expression within infected cells [11] . Notably, the DENV NS2B-3 protease complex, by cleavage and degradation of an adapter of the cytoplasmic sensor-mediated signaling (STING, also called MITA) and by preventing phosphorylation and nuclear translocation of the downstream transcriptional factor, IFN regulatory 3 (IRF3), inhibits type I IFN production in DENV infected cells [12, 13, 14, 15] . Despite these potent inhibitory mechanisms, expression of antiviral and inflammatory molecules is readily detected in DENV infected humans [16, 17] . Their levels play a pivotal role in DENV infection clearance and pathogenicity [16, 18, 19] , thus highlighting the importance of elucidating the host sensing mechanisms leading to the IFN response during DENV infection.
Here, we showed that pDCs are robust IFNa producer cells in response to DENV infected cells. In addition, we demonstrated that cell-to-cell contact-and TLR7-dependent pDC responsiveness leads to an antiviral state, inflammatory cytokine production as well as expression of co-stimulatory molecules by pDCs. Newly formed particles of DENV, like many viruses, undergo maturation by cleavage of the virus envelope protein, premembrane (prM), in the secretory pathway that renders the virus infectious [20] . Yet, the prM cleavage site is suboptimal, leading to the secretion of about 30-40% immature, prM-bearing particles [21, 22, 23, 24, 25, 26] . This evolutionarily conserved suboptimal site may be critical for the export of the infectious viral particles and/or may also positively contribute to viral infection by usurpation of humoral immune response, because anti-prM antibodies facilitate efficient binding and cell entry of prM-containing immature particles into Fc-receptor-expressing cells, a process called antibody dependent enhancement (ADE) [21, 22, 23, 27, 28] . Here, we report a previously unsuspected function of immature particles in innate immunity. Although the immature particles are not infectious, they are fully competent to trigger a robust type I IFN response by contacting non-permissive pDCs. Our results highlight the trade-off between efficient secretion of infectious viral particles and the production of a large amount of IFN-inducing immature particles.
Results

IFNa is robustly produced by pDCs in contact with DENV infected cells
To investigate the mechanisms regulating the IFN response against DENV infection, primary human peripheral blood mononuclear cells (PBMCs) from healthy donors were exposed to supernatants containing DENV virions or DENV infected cells. We found that PBMCs specifically responded to co-cultivation with DENV infected cells but not to uninfected Huh7.5.1 cells, by a robust secretion of IFNa ( Figure 1A ). In sharp contrast, supernatants from the DENV infected cells failed to trigger IFNa secretion by PBMCs ( Figure 1A ). Plasmacytoid dendritic cells (pDCs), which represent a rare PBMC population, i.e. 0.41% of PBMCs ( Figure 1B , upper panel), are known to produce IFNa [9] . Antibody-mediated pDC depletion from PBMCs ( Figure 1B , middle panel) abolished IFNa secretion in response to co-culture with DENV infected cells ( Figure 1A ). Similar results were also obtained using DENV infected BHK-21 cells (Figures S1A and S1B). To rule out potential non-specific effects of the depletion procedure on innate cell responsiveness, we verified that IL-6 production triggered by lipopolysaccharide (LPS) exposure was maintained after pDC depletion ( Figures 1C and S1C) . Consistent with the depletion results, the isolated pDC population ( Figure 1B , lower panel) potently produced IFNa in response to co-culture with DENV infected cells, but not in the presence of their supernatants ( Figure 1A) . A very limited number of pDCs (i.e., 2,000 pDCs) was sufficient to produce a robust secretion of IFNa ( Figure 1A ). Similar levels of IFNa production were detected after co-culture of infected cells with isolated pDCs as compared to total PBMCs, which contained a similar number of pDCs ( Figure 1D ), further suggesting that pDCs are the main IFNa producer cells among PBMCs. We showed that the cells productively infected with DENV did not produce IFNa themselves ( Figure S2A ). The pDC IFNa response increased as the duration of infection and, thus the replication levels, prior to co-culture increased ( Figure  S2A ). Remarkably, similar levels of IFNa secretion were reproducibly obtained with pDCs isolated from the blood of a cohort of 20 healthy donors ( Figure 1E ). Together these results suggest that pDCs represent the main cell type in PBMC populations that produce IFN in response to co-cultivation with DENV infected cells and that this response was not induced by the addition of cellfree supernatants containing virus.
To exclude the possibility that pDCs respond transiently to supernatants containing DENV, we quantified IFNa secretion in time course experiments. IFNa secretion was already detectable as early as 4 hours after co-cultivation of pDCs and DENV infected cells ( Figure 2A ). IFNa levels concurrently increased over the time course of co-culture of DENV infected cells with either pDCs or PBMCs, and reached levels around 100 ng/mL after 16 hours of co-culture ( Figure 2A ). In contrast, cell-free supernatants containing DENV did not trigger detectable IFNa production by pDCs or by PBMCs at any of time points analyzed (Figure 2A ). IFNa
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producer cells were markedly enriched in pDCs, characterized as a CD123-positive population, as compared to the CD123-negative population ( Figure 2B ). For example, 12 hours after co-culture of DENV infected cells with PBMCs, <0.05% and <25-30% of CD123-negative and -positive cells, respectively, were IFNa positive ( Figure 2B ). Consistently, the frequencies of IFNa producer cells (i.e., about 30%) among pDCs (i.e., CD123-positive populations) were comparable in co-cultures of DENV infected cells with PBMCs vs. isolated pDCs ( Figure 2B ). Together these results suggested that IFNa is robustly produced only by pDCs that are co-cultured with DENV infected cells.
Sensing of cells infected by different members of the Flavivirus genus by pDCs is not cell-type restricted
Next, we showed that co-cultivation of DENV infected primary cells, i.e., monocyte-derived macrophages (mo-M) and monocyte- 6 foci forming units (ffu)/ml. pDC depletion/enrichment was performed using an anti-BDCA-4 antibody. Cell #; number of co-cultured responder cells. Cont cells; uninfected Huh-7.5.1 cells. Arrows indicate results below the detection threshold of the IFNa ELISA (i.e., 12.5 pg/ml). Results are representative of 4 independent experiments. Error bars represent the means 6 SD. (B) Representative FACS analysis of pDC depletion and isolation from PBMCs using the pDC selective markers, CD123 and BDCA-2. (C) Quantification of IL6 in the supernatants of PBMCs and pDC-depleted PBMCs triggered by LPS (10 mg/mL for 20 hours). Results are expressed as percentage relative to LPS-treated PBMCs. 3 independent experiments in triplicate (error bars, means 6 SD), paired Student's t test, ***p,0.0001, NS p.0.1, D; indicates separated group by ANOVA. (D) Total PBMC population containing a number of pDCs equivalent to the purified pDCs as determined by FACS analysis as described in (B) were co-cultured with DENV infected cells. IFNa productions were thus compared for equal numbers of pDCs. PBMCs and pDC-depleted PBMCs were compared using equal cell numbers. The results are expressed as IFNa levels relative to the co-culture with PBMCs, set at 100, 3 independent experiments in triplicate, paired Student's t test, ***p,0.0001, NS p.0.05, D; indicates separated group by ANOVA (error bars, means 6 SD). (E) Quantification of IFNa secretion by pDCs isolated from the blood of a healthy donor cohort (n = 20) cocultured with infected cells or treated with their supernatant. IFNa levels in the supernatants of pDCs co-cultured with uninfected (cont) cells or with DENV SN were all below the detection threshold (i.e., 12.5 pg/ml). doi:10.1371/journal.ppat.1004434.g001 derived dendritic cells (mo-DC) with pDCs (isolated from the same donor), potently triggered pDC IFNa secretion ( Figures 3A and  3B ). This stood in stark contrast to the corresponding cell-free supernatants containing virus or the parental uninfected cells did not, or very weakly, induced pDC IFNa production ( Figures 3A  and 3B ). Consistent with the previously reported inhibition of type I IFN production by the DENV NS2B-3 protease in infected cells [12, 13, 14, 15] , DENV infected primary cells did not produced detectable levels of IFNa ( Figures 3A and 3B) .
Additionally, we determined if the production of IFNa by pDCs could be reproduced in response to co-culture with various cell types infected by DENV. Robust secretion of IFNa was triggered when pDCs were co-cultivated with DENV infected cell lines from different origins (i.e., human Huh7.5.1, Hela and 293T cells or non-human BHK-21 and Vero cells), but not by the corresponding supernatants containing virus or the uninfected cells ( Figure 3C ). DENV infected Vero cells were weaker IFNa inducers ( Figure 3C ), consistent with lower levels of intracellular DENV RNA ( Figure 3D ) and infectious viral particle (Figure 3E) produced by these cells, suggesting that pDC IFNa induction is proportional, to some degree, with the level of viral replication.
Remarkably, 293T cells infected by another member of the Flavivirus genus, West Nile virus (WNV), but not the corresponding cell-free supernatants containing virus, also triggered robust IFNa production when co-cultured with pDCs ( Figure 3C ). Similar to the results obtained using co-cultures with DENV infected cells, the pDC IFNa responses increased as the numbers of WNV infected cells increased ( Figures S2B and S2C) . Together, these results demonstrated that the production of IFNa by pDCs in response to co-culture with DENV infected cells is not cell type specific and that pDCs similarly respond to another member of the Flavivirus genus.
Short range sensing of infected cells by pDCs triggers the IFNa response
Cell-free supernatants containing virus from various infected cell types failed to trigger pDC IFNa production, even when added as crude non-filtered supernatants containing virus at to DENV. Similarly to IFNa, pDCs robustly produced IFNb when in contact with DENV infected cells, but not when cells were physically separated by a transwell membrane ( Figure 4D ). Consistent with these results, IFNb production by pDCs was not triggered by supernatants from DENV infected cells and DENV infected cells did not themselves release detectable levels of IFNb ( Figure 4D ). In control experiments using identical transwell culture settings, an agonist of TLR7, a viral RNA immune sensor [9] , triggered the production of both IFNa and IFNb by the pDCs at levels similar to those obtained in the co-culture setting ( Figure 4C and 4E) , thus ruling out potential non-specific effects of the experimental setting on pDC responsiveness. In agreement with previous reports [29, 30] , vesicular stomatitis virus (VSV) or Influenza virus (FluAV) containing supernatants robustly triggered IFNa production by pDCs ( Figure 4F ). Consistent with these results, VSV and FluAV infected cells in contact with pDCs ( Figure 4F , cocult) or separated by a transwell membrane ( Figure 4F , TW), triggered IFNa production at similar levels. This suggested that contact with virus infected cells is not a universally employed mechanism to promote pDC activation by RNA viruses. Next, viral transmission across the transwellmembrane was assessed by quantifying infectious DENV (Figure 4G ) and WNV ( Figure 4H ) on both sides of the membrane that separated infected cells from recipient cells. To evaluate the possible interference of recipient cells on the extracellular infectivity detection, we compared two types of recipient cells, i.e., IFNa response-competent pDCs, which are non-permissive to infection ( Figure S4 ) and permissive cells ( Figure 4G DENV infected cells transmit viral RNA to pDCs and induce a TLR7-mediated antiviral state and pDC maturation pDCs typically respond to viral infection via endolysosomelocalized TLR7-or TLR9 sensors that recognize RNA or DNA viral genomes, respectively [9] . Accordingly, we examined the transmission of DENV RNAs to co-cultured pDCs. The presence of DENV RNA in infected cells and co-cultured pDCs (selectively labeled with DiI, a fluorescent membrane dye) was assessed using a highly sensitive DENV RNA-specific fluorescence in situ hybridization (FISH) assay ( Figure 5A , upper panels). The analyses were performed after 5 hours of co-culture with DENV infected cells, at which time pDCs already produced IFNa (Figure 2A ). DENV RNA (green) was detected as discrete dots inside pDCs ( Figure 5A , lower panels). Inspection of consecutive Z-axis sections of cocultures stained by combined DENV RNA FISH and anti-IFNa immuno-detections revealed that the frequency of DENV RNApositive pDCs was elevated in both IFNa-positive (i.e., 85%) and IFNa-negative pDCs (i.e., 74.5%) ( Figure 5A, summary table) . The specificity of these examinations was validated by the absence of DENV RNA-positive pDC when co-cultured with uninfected cells and when the FISH procedure was performed in the absence of the DENV RNA specific probe ( Figure 5A , summary table and Figure S5 ). The presence of DENV RNA in IFNa-negative pDCs may reflect the time required for DENV RNA to trigger pDCs to produce enough IFNa to be detectable, which may not have occurred by 5 hours of co-cultivation. Alternatively, differential DENV RNA localization in intracellular compartments may modulate their recognition by innate sensors, and/or potential subsets of pDCs may be differentially responsive to the DENV RNA stimulus, in accordance with the maximal detection of about 30% IFNa-positive pDCs at plateau ( Figure 2B) . Only a few DENV RNA dots were detected inside pDCs, suggesting that it is a rare event but sufficient to trigger pDC IFN production. Together, these results indicated that DENV RNA was readily transmitted from DENV infected cells to co-cultured pDCs, supporting the notion that DENV RNA might be recognized by pDC TLR7. Accordingly, a TLR7 antagonist significantly inhibited pDC IFNa production induced by DENV infected cells ( Figure 5B ). The specificity of this TLR7 antagonist was demonstrated by the inhibition of IFNa production induced by a TLR7 agonist (R848) but not by a TLR9 agonist (ODN2216) ( Figure 5B ). Collectively, these results suggested that DENV infected cells transfer viral RNA to co-cultured pDCs and trigger TLR7-dependent IFNa production.
Next, to further define the nature of the pDC-mediated antiviral state induced by contact with DENV infected cells, we examined the secretion of the inflammatory cytokines, IL-6 and tumor necrosis factor (TNF)-a, triggered by activation of the transcription factor NF-kb, known to transduce antiviral signaling downstream of TLR7 [1] . TNF-a is known to play a pivotal role in the vascular leakage syndrome, a hallmark of dengue hemorrhagic fever [18] . Sensing of DENV infected cells, but not their supernatants, specifically triggered pDCs to produce IL-6 and TNF-a at levels comparable to those induced by treatment with a TLR7 agonist ( Figure 5C ). In addition, ISGs (i.e., MxA and ISG56) were specifically up-regulated in co-cultures of DENV infected cells with pDCs or PBMCs ( Figure S6 ), thus indicating the establishment of an antiviral state.
Finally, we determined if DENV infected cells trigger pDC maturation as assessed by the up-regulation of the CD83 and CD86 markers at the cell surface. DENV infected cells, but not their supernatants, triggered a rapid increase in the surface expression of CD83 on co-cultivated pDCs (i.e., in CD123 marker-gated cells) ( Figure 5D , left panel), accompanied by a slightly delayed augmentation of CD86 cell surface expression ( Figure 5D , left panel) and by a concomitant increase in IFNa secretion ( Figure 5D , right panel). Collectively, these results demonstrated that sensing of DENV infected cells by TLR7, a sensor of single stranded-RNA, triggers IFNa production by pDCs, along with the induction of the inflammatory response, an antiviral state and pDC maturation.
The IFNa response by pDCs is modulated by DENV glycoproteins
To define how pDCs sense DENV infected cells, we analyzed the ability of cells harboring recombinant DENV genomes containing mutations specifying phenotypes deficient in various viral functions to trigger IFNa production by co-cultured pDCs. First, we tested cells containing DENV genomes encoding lethal mutations in the methyltransferase domain of the viral NS5 polymerase (i.e., Rep 2/2 ) [31] . As expected [31] , the triple mutation significantly reduced the intracellular level of DENV RNA at 48 hours post-transfection as compared to the wild type (WT) genome ( Figure 6A ), reflecting a failure to amplify viral RNA ( Figure S7A ). Consistently, this mutant did not express Figure S7B ), failed to induce IFNa production by co-cultured pDCs ( Figure 6D ). Together these results indicated that the pDC IFNa response requires active viral replication in neighboring DENV infected cells.
Next, to address the requirement of viral genome release for pDC activation, we tested the effects of co-culture with cells harboring DENV genomes encoding point mutations in the envelope (E) glycoprotein, i.e., the substitutions D215A, H244A or P217A, known to inhibit infectious viral production [32, 33] . Consistent with previous reports [32, 33] , the E glycoprotein mutations did not impair intracellular levels of either viral RNAs or proteins (Figures 6A, S7A and S7B), but they all greatly compromised the production of infectious particles ( Figure 6B ). Both the D215A and H244A mutations abrogated the release of viral RNA and structural proteins and the pDC IFNa response (Figures 6C-D and S7C). Conversely, cells harboring DENV genomes encoding the P217A mutation triggered the IFNa response by pDCs (i.e., <36% relative to WT) ( Figure 6D ) at various inducer cell concentrations ( Figure S7D ) and in proportion to the release of extracellular DENV RNA (i.e., <60% and 26% relative to WT at 24 and 48 hours post-transfection, respectively) ( Figure 6C ) and viral structural proteins ( Figure S7C ). Remarkably, the production of infectious virus ( Figure 6B ) was severely and disproportionally inhibited by the P217A mutation (i.e., 40-to-1,000 fold-reduction at 24-to-48 hours post-transfection) as compared to the modest inhibition of the IFNa response by pDCs (i.e., <2.5 fold-reduction of IFNa response in the same time period) ( Figure 6D and S7D). These results suggested that infectious virus production is not required and/or is not ratelimiting for pDC activation. Consistently, pDCs were not permissive to DENV infection ( Figure S4A ), this latter observation is in line with the previous demonstration of pDCs as refractory to infection by other viruses [30, 34, 35] .
Altogether, these results suggested that glycoprotein-dependent release of non-infectious viral components by DENV infected cells might trigger the IFNa response by contacting pDCs.
DENV envelope protein-dependent transfer and activation of IFNa response by pDCs
To determine whether DENV surface proteins mediate the transmission of viral components to pDCs, we first assessed whether, similarly to DENV RNA ( Figure 5A ), the DENV envelope proteins are transmitted into the pDCs, by inspection of consecutive Z-axis sections of DiD-labeled pDCs in co-culture with cells harboring the WT and DENV genomes encoding E protein mutations ( Figure S8 ). Similar to DENV genome, we observed the E glycoproteins (E GP) in dot-like structures inside the pDCs. The frequencies of E GP dot-positive pDCs were elevated when in the co-cultures with either cells harboring the WT genome (i.e., around 90%) or the P217A mutation (i.e., above 65%) (Figures 6E and S8), which was in proportion to the release of extracellular DENV RNA (i.e., 60% relative to WT particles at 24 hours post-transfection) (Figures 6C). In contrast, cells harboring the DENV genome encoding the H244A mutation in E, which do not release viral particles and fail to trigger the IFN response by pDCs ( Figures 6B, 6C , 6D, S7C and S7D), demonstrated little to no transmission of the E GP into the pDCs ( Figures 6E and S8 ). Because the intracellular levels of viral components (i.e., viral RNA, E and capsid proteins) were equivalent for cells harboring DENV genomes encoding the H244A point mutant, as compared to WT genome ( Figures 6A and S7B ), the results suggested that pDC IFNa production is activated by the glycoprotein-mediated transmission of viral components from DENV infected cells into contacting pDCs.
Next, we tested the impact of expressing the DENV surface proteins alone ( Figure S9A ) on pDC IFN induction. Expression of the envelope proteins alone is known to result, in absence of nucleocapsid, in the release of viral envelope containingmembrane vesicles, the sub-viral particles (SVPs) ( Figure S9B ) [36] . Although the glycoproteins were readily transmitted from cells expressing only the DENV surface proteins to the co-cultured pDCs ( Figure S9D-F) , IFNa production was not triggered ( Figure  S9C ). These observations are in agreement with the transmission of DENV RNA to pDCs and activation by the TLR7 RNA sensor ( Figure 5A and 5B).
To corroborate these results, we determined whether pDC activation by contact with DENV infected cells requires an internalization-dependent mechanism by testing inhibitors of dynamin (Dynasore) [37] , of clathrin-mediated endocytosis (Chlorpromazine [38] ) and of macropinocytosis (Gö6983-PKC inhibitor [39, 40] ). Inhibitors of both dynamin and clathrinmediated endocytosis, but not macropinocytosis, abrogated pDC IFNa production triggered by DENV infected cells ( Figure S10A ), without any effect on the ongoing DENV replication and viral production ( Figures S10B-C) . In addition, these inhibitors did not markedly impair pDC IFNa production induced by a TLR7 agonist ( Figure S10A ), a cell-permeable imidazoquinoline, which passively diffuses inside the pDCs [41] , thus ruling out potential side-effect downstream of TLR7 recognition. These results, in agreement with the requirement of the endolysosome localizedsensor, TLR7 ( Figure 5B), suggested that pDC IFNa production triggered by DENV infected cells requires glycoprotein-mediated n = 4; Hela cells/DENV, n = 2; Vero cells/DENV, n = 2; 293T cells/WNV, n = 2. Huh7.5.1 cells/DENV were included in each independent experiment (n = secretion of non-infectious viral components, which are subsequently internalized by co-cultured pDCs. These results demonstrated that pDC activation triggered by DENV infected cells is distinct from that induced by cells infected by other viruses, such as HCV, LCMV and classical swine fever virus (CSFV), which does not require viral structural protein expression [4, 5, 7] .
Disruption of cell contact and DENV surface protein clustering by cytoskeleton inhibitors abrogates the pDC IFNa response
Next, we sought to study the regulation by cell contacts of DENV surface protein-dependent transfer and activation of pDCs. First, the cytoskeleton organization at the cell interface between pDCs and DENV infected cells was determined by confocal microscopy analysis. We observed an accumulation of the actin network at the cell contacts ( Figure 7A-E) , while the microtubule network was not markedly modified at this location ( Figure S11A , left panel). In agreement with the importance of secreted structural components for pDC activation (Figure 6 ), specific immunostaining of non-permeabilized cells revealed that envelope proteins (i.e., E GP and prM) were both present as clusters at the interface between pDCs and infected cells (Figures 7F-Q and S12).
These observations prompted us to define the impact of the cytoskeleton network on cell contact-dependent pDC IFNa production. We showed that two inhibitors of the cytoskeleton network, Latrunculin B and Nocodazole (i.e., actin and microtubule depolymerizing drugs, respectively) disrupted the actin network in co-cultures of pDC/DENV infected cell ( Figure 8A ), consistent with previous reports [42, 43] . As expected, the microtubule network was only perturbed by Nocodazole treatment ( Figure S11A ) [44] . By imaging flow cytometry analysis of GFP expressing-DENV infected cells co-cultured with pDCs (stained by pDC marker CD123) (Figures S13), we showed that the frequency of conjugates between pDCs and DENV infected cells was greatly decreased by inhibitors of the cytoskeleton network ( Figure 8B and S13). Both these inhibitors, in conjunction with the loss of actin accumulation at the contacts ( Figure 8A) , impaired E glycoprotein clustering ( Figure 8C ). Indeed, quantifications performed in a ''double-blind'' set-up revealed that, while E GP clustering was readily observed at the cell interface in untreated co-cultures (i.e., <60% of the pDCs at close proximity with DENV infected cells harboring E GP clustering), these frequencies were reduced to 15% for co-cultures treated with either inhibitor ( Figure 8D ). Importantly, similar treatments inhibited IFNa production by the pDCs ( Figure 8E ). Neither compound inhibited DENV RNA replication in the infected cells and infectious viral production ( Figures 8F-G) , nor did they prevent the internalization ability of pDC, as assessed by membrane dye uptake ( Figure S11B ). In addition, they did not inhibit pDC IFNa production triggered by a TLR7 agonist ( Figure 8E ), thus ruling out potential nonspecific effects of these compounds on pDC responsiveness.
Altogether, these results suggested that the cytoskeletondependent regulation of cell contacts and apposed GP clustering likely favors the subsequent activation of IFNa production by the pDCs.
Cell producing immature DENV particles trigger pDC IFNa production more potently than cells releasing mature virus
The phenotypic analysis of a virus production defective mutant (i.e., P217A) ( Figure 6 ) revealed that infectious virus production is not required and/or is not rate-limiting for pDC activation.
Like many viruses, DENV infected cells release immature noninfectious particles harboring uncleaved precursor membrane proteins (prM), that are generated by inefficient cleavage of prM by the resident trans-Golgi protease furin [21, 22, 23, 24, 25, 26] . To determine whether immature particles can serve as vehicles from DENV infected cells to contacting pDCs, we first determined the presence of prM protein dots inside co-cultured pDCs by using an antibody recognizing the pr peptide [45] and by examining consecutive Z-sections by confocal microscopy analysis. Dots of prM were observed inside pDCs co-cultured with DENV infected cells (Figures S14A and S14C) with very little background staining in pDCs co-cultured with uninfected control cells (Figures S14B and S14C), suggesting that prM (and/or pr peptide), along with the E GP (Figures 6E, S8 and S9) are readily transferred to the pDCs.
Next, to determine the ability of immature particles to convey immunostimulatory RNAs to pDCs, we tested the effects of DENV genomes encoding mutations in the furin cleavage site of the prM protein (i.e., the substitutions R88A, K90A and R91A), which, as expected from previous reports with single mutations [26] , failed to produce infectious virus ( Figure 9C ). By contrast, RNA replication, intracellular viral protein expression (Figures 9A, S7A and S7B), release of viral components ( Figures 9B and  S7C) , and transmission of viral components to the pDCs ( Figures 9D and S8D ) were maintained at levels comparable to the WT counterparts. Remarkably, the pDCs produced similar levels of IFNa when comparing contacting cells producing noninfectious immature virions vs WT DENV ( Figure 9E ). Similar results were obtained when using various concentrations of cells harboring WT/mutant DENV genome ( Figure S7D ). Therefore, these results suggested that cells producing immature particles potently trigger IFNa production by contacting pDCs.
Next, to define the specific function of uncleaved prMcontaining particles in pDC activation by DENV infected cells, we designed experiments aiming at modulating the levels of prM maturation. Firstly, we assessed the impact of an inhibitor of furin. As expected, this inhibitor markedly decreased the maturation of DENV particles, as shown by an increased prM:E ratio measured by ELISA ( Figure 9F ). The production of extracellular infectious DENV was also reduced in a dose-dependent manner upon furin treatment ( Figure 9H ), while the levels of intracellular DENV RNA were unchanged ( Figure 9G) . Remarkably, inhibition of prM cleavage enhanced IFNa productions by co-cultured pDCs in a dose-dependent manner ( Figure 9I ). Increased pDC activation was observed despite a reduction in the release of physical particles, as shown by extracellular DENV RNA measurement ( Figure 9H ). Altogether these results suggested that the activation of pDCs triggered by contacting infected cells inversely correlates with the levels of prM maturation.
To further confirm these results, we studied the impact of furin up-regulation. As expected, cells overexpressing furin produced viral particles containing reduced prM:E ratios (i.e., <10-fold reduction) ( Figure 9J ). The specific infectivity of DENV particles was increased upon furin overexpression (i.e., <3-fold increase in the ratios of infectivity to extracellular DENV RNA, comparing furin-overexpressing cells to counterpart control cells). Thus, cells overexpressing furin were compared to counterpart cells that produced either similar levels of intracellular and/or extracellular DENV RNA, or alternatively, similar production of infectious virus, by using different MOIs (Figure 9K-L) . Our results indicated that cells producing more mature particles were clearly impaired at triggering IFNa production by co-cultured pDCs ( Figure 9M ).
Altogether these results demonstrated that cells producing immature DENV particles are very potent at inducing IFNa production by pDCs, as compared to cells releasing mature virions.
Discussion
DENV has rapidly emerged in recent years as the most significant arboviral disease of humans, with greater than half of the world population at risk of infection [46] . Despite many years of research, the virus-host interactions that determine dengue pathogenesis are still incompletely understood [47] . Nonetheless, the self-limiting febrile symptoms observed in most DENVcontracted cases and the short course of illness suggest a key role for innate immune defenses in controlling DENV infection at early stages [18] . Accordingly, in vivo studies have demonstrated a critical role for type I IFNs in the host defense against DENV [16, 18, 19] . Furthermore, the activation of pDCs strongly correlates with the disease outcome of DENV infected patients [48] . Importantly, a study of children with DENV infections across a broad range of illness severities suggested that a blunted blood pDC response to systemic infection was associated with higher viremia levels and was a key step in the pathogenic cascade toward severe disease [49] . Although the activation mechanism and exact function are still elusive, altogether, these findings highlight the critical roles played by pDCs and the IFN response on disease progression in DENV infected individuals. Here, we revealed that DENV infected cells potently trigger IFNa secretion by nonpermissive pDCs, a host response that bypasses the evasion from the innate response within infected cells. Furthermore, we demonstrated that TLR7-dependent IFNa production by pDCs in response to infected cells is concurrent with other hallmarks of innate immunity, such as inflammatory cytokine secretion, ISG up-regulation and pDC maturation.
In agreement with our results, Rodriguez at al. showed that DENV-containing supernatants failed to trigger pDC IFNa production [50] , while other reports suggested that they triggered pDC activation [48, 51] . This discordance may be explained by the preparation and concentration of supernatants and large number of pDCs that were used in the latter reports. Remarkably, the results of our study demonstrated that, despite continuous exposure to the infected cell milieu, physical separation from infected cells precludes the IFN response by pDCs. Consistently, strong pDC IFNa secretion was induced by co-cultured DENV infected cells (i.e., up to 0.5 mg/ml), indicating that cell-to-cell contact is a key feature of pDC activation. Interestingly, cell-to-cell transmission of immunostimulatory signals appears to be a common characteristic of pDC induction, as shown in this report for two members of the Flavivirus genus, DENV and WNV and as previously reported for other viruses, i.e. HCV, HIV, LCMV and CSFV [3, 4, 5, 6, 7] . Specifically, our previous results obtained in the context of HCV indicated that pDC stimulation occurs via viral RNA-containing exosomes. In this context, we suggested that the concentration of immunostimulatory exosomes in the supernatants was below an activating threshold for pDC stimulation, while this threshold might be reached in the intercellular space when cells are in contact [3] .
Importantly, we showed here that viral structural components are detected in clusters at the interface between pDCs and infected cells. This finding suggests that cellular surface molecules and/or structures might concentrate the PAMP-carrier at the cell contacts, thereby enhancing transmission to pDCs. We further revealed that the actin network is pivotal for both this clustering of viral components at the pDC-infected cell interface, likely by regulating cell-to-cell contacts, and for pDC activation. Based on this observation, it is conceivable that the cytoskeleton structure serves as a platform contributing to the cell-to-cell transmission of viral components to the pDCs. Additional experiments will be required to test these hypotheses and to determine whether, for the various viruses that trigger the pDC IFN response in a cell-to-cell contact dependent manner, the mechanism of activation involves either common or distinct cellular factors and/or structures at the contacts.
The mechanism we have identified is distinct from the conventional induction of the innate response, which typically occurs by the recognition of viral nucleic acids within infected cells [1, 2] . Moreover, in contrast with the previously characterized induction of pDC IFNa production through contact with infected cells [3, 4, 5, 7] , here we have defined a sensing pathway, which requires an E glycoprotein-dependent secretion of viral components, notably viral RNA, to trigger the pDCs. As such, it is different from the mechanism of induction by cells infected by other viruses, which does not require viral structural proteins [3, 4, 5, 7] . Indeed, our results illustrate the crucial role of DENV envelope proteins in the induction of the innate response by neighboring IFN producer pDCs that are not permissive to infection. Importantly, our results revealed that cells producing uncleaved prM-containing immature particles triggered IFNa by pDCs more potently than cells efficiently producing fully mature pDCs in co-cultures for 8 hours. Results are expressed as the percentages of DiI stained pDCs that contain E GP dot(s) detected by immunostaining and analyzed by confocal microscopy. Representative pictures are displayed in Figure S8 . Similar results were obtained in 3 independent experiments and <20 pDCs surrounded by E GP positive/DiI negative cells were observed per experimental condition. doi:10.1371/journal.ppat.1004434.g006
virions. These immature particles are known to be deficient for the membrane fusion step, which occurs in the endo-lysosomal compartment during cell entry [52, 53, 54] . Interestingly, recognition of viral RNA by TLR7 sensor also takes place in this cellular compartment [1, 55] . Therefore, based on these findings, we suggest a working model in which an extended retention within the endosomal compartment of fusogenic-deficient immature particles may favor the exposure of their viral genome for TLR7 recognition. In contrast, mature virions, which are fusioncompetent, could escape from this compartment by membrane fusion. Additional experiments will be required to firmly validate and generalize this new concept.
Several reports have demonstrated that a large proportion of uncleaved prM-containing immature particles are released from DENV infected cells, i.e., 30-to-40% of viral particles [21, 22, 23, 24, 25, 26] , on which prM content is variable on a perparticle basis [56, 57] . Consistently, we showed that furin overexpression reduced the levels of immature virus, otherwise, produced by DENV infected cells, and concomitantly with reduced pDC IFN response. Although direct proof is still required, current evidence supports the in vivo existence of uncleaved prMcontaining virus. Previous studies have demonstrated that a proportion of B cells isolated from DENV infected individuals produces monoclonal antibodies against prM [58, 59] . In addition, the characterization of these anti-prM antibodies indicated that they are a major component of the serological response to DENV infection, leading to increased replication in Fc receptor-bearing cells via antibody-dependent enhancement (ADE) [56, 58, 60] . Importantly, our results illustrate a previously unsuspected function of these immature particles in innate immunity in mediating an IFN response by non-permissive bystander pDC. Indeed, the results of our study imply that the suboptimal furincleavage sequence, likely evolutionarily conserved to favor efficient export of infectious virus by preventing premature membrane fusion in the secretory pathway and cell entry of immature virus into Fc-receptor-expressing cells by ADE [21, 22, 23, 27, 28] , might also, by producing an IFN-inducer, contribute to regulate dengue pathogenesis. It is possible that pDC activation by infected cells elicits a strong local innate response that may lead to viral replication suppression or, alternatively, to the possible subsequent recruitment of DENV permissive cells and systemic viral spread. It is also conceivable that the interplay between pDCs and other cells regulating the innate responses, in turn, modulates this newly identified innate sensing mechanism of infected cells and/or the homing of pDCs to the infection site.
Productive infection of cells with a wide range of enveloped viruses depends critically on the processing of the viral surface glycoproteins by cellular proteases [20] . Yet, depending on viral variants/strains, such cleavages might be limited by the differential requirement for certain host proteases, as their expression can be tissue-restricted. These selective requirements may contribute to their virulence, as proposed for influenza virus [61] . Additionally, suboptimal cleavage sites are evolutionarily maintained by sequence features, such as, e.g., the presence of acidic residues or glycosylation sites adjacent to the cleavage site [23, 62] . These events lead to the release of viral particles with uncleaved glycoproteins, as shown for viruses such as, e.g. measles virus [63] , influenza virus [61, 64] , DENV and WNV [53, 56] . Therefore our results, by uncovering a functional role of immature viral particles in innate immunity, may have broad implications for our understanding of the host-virus relationship.
Materials and Methods
Biological materials
Huh-7.5.1 [65] , Vero E6 (ATCC CRL-1586), Hela (ATCC CCL-2) and HEK-293T (ATCC CRL-1573) cells were maintained in Dulbecco's modified Eagle medium (DMEM) (Life Technologies) supplemented with 10% FBS, 100 units (U)/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine and nonessential amino acids (Life Technologies) at 37uC/5% CO 2 . BHK-21 cells (ATCC CCL-10) were maintained in Eagle's MEM (Life Technologies) with the same supplements. pDCs were isolated from 450 ml of blood from healthy adult human volunteers which was obtained according to procedures approved by the ''Etablissement Français du sang'' (EFS) Committee. PBMCs were isolated using Ficoll-Hypaque density centrifugation. pDCs were positively selected from PBMCs using BDCA-4-magnetic beads (MACS Miltenyi Biotec) and cultured as previously described [3] . Monocytes were positively selected from pDC-depleted PBMCs using CD14-magnetic beads (MACS Miltenyi Biotec) according to the manufacturer's instructions, with a typical purity of 95% of CD11c-positive cells. CD14+ cells were then differentiated to monocyte-derived DCs (mo-DCs) by incubation for 6 days in RPMI 1640 medium supplemented with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, nonessential amino acids, 1 mM sodium pyruvate and 0.05 mM bmercaptoethanol (Sigma-Aldrich) with 500 U/ml human granulocyte-macrophage colony-stimulated factor (GM-CSF) and 2,000 U/ml human interleukin 4 (IL-4) (MACS Miltenyi Biotec), as previously described [12] . To generate monocyte-derived macrophages, monocytes were cultured in the same medium as for the mo-DCs with 500 U/ml GM-CSF for 6 days.
Reagents
The antibodies used for immunoblotting were mouse anti-E glycoprotein (4G2 and 3H5) kindly provided by P. Despres (Pasteur Institut, Paris, France); mouse anti-capsid (6F3) kindly Introduction of mutations into the genomic length DENV-2 strain NGC cDNA clone pDVWS601, encoding amino acid substitutions into the E glycoprotein (i.e., H244A, D215A, P217A) and NS5 (i.e., Rep 2/2 , containing the multiple amino acid substitutions G81A, G83A and G85A) have been described previously [31, 32] . Mutations encoding amino acid substitutions in prM (amino acids R88A/K90A/R91A) and an in frame four amino acid deletion in the capsid (amino acids V51-to-L54) were first introduced into DENV-2 subgenomic cDNA fragments by overlap-PCR (OL-PCR) using mutagenic primers. The sequences of the primers are described in the Table S1 . The OL-PCR fragments were purified and cleaved with BsrGI and SphI and then transferred into the pDVWS601 plasmid that had been cleaved with the corresponding restriction enzymes. The presence of the mutations and sequence of the PCR derived regions were confirmed by sequencing.
In vitro RNA transcripts were prepared from the parental and mutated pDVWS601 plasmids as described above and transfected into Huh7.5.1 cells using the Lipofectamine 2000 transfection reagent (Life Technologies), according to the manufacturer's instruction. One mg of RNA was used to transfect a 60% confluent cell monolayer contained in a single well of a 6-well plate following the manufacturer's protocol. Six hours post-transfection, the cells were either harvested for the quantification of viral RNA (6 hour time point) or washed 3 times with PBS and fresh culture medium added to the cells for additional incubation times. At 24 and 48 hours post-transfection, the cells were harvested for the determination of RNA and protein levels and their supernatants collected for the quantification of viral RNA and infectious titer or concentrated by ultracentrifugation for the determination of protein levels by Western blot. At 24 hours post-transfection, the cells were harvested and co-cultured with isolated pDCs for 18-20 hours.
Co-culture experiments
Forty-eight hours prior to co-culture, cells were infected at a MOI of 3 using a viral stock of WNV or DENV. Unless otherwise indicated, 2610 4 pDCs were co-cultured with 10 5 infected cells, transfected cells or uninfected parental cells, or treated with 100 ml of supernatant from the latter cells in a 200 ml final volume in 96-well round-bottom plates incubated at 37uC/5% CO 2 . Eighteen to twenty hours later, cell-culture supernatants were collected and the levels of IFNa, IFNb, TNFa and IL-6 were measured using a commercially available ELISA kits specific for IFNa and IFNb 
Immunostaining and FACS analysis
At the indicated times, cells were harvested and resuspended using 0.48 mM EDTA-PBS solution (Life Technologies). After with extracellular prM:E ratios (J), intracellular DENV RNA (K), extracellular DENV RNA and infectious virus production (L), and quantification of IFNa secretion by co-cultured pDCs (M). Results are expressed relative to 293T cells infected at a MOI of 1 in absence of Furin overexpression (indicated as 293T-1), set to 100 (error bars represent the means 6 SD, 3 independent experiments in triplicates). Arrows indicate results below the detection limit of assay as described in the legend of Figure 6 . NA; Not Applicable. doi:10.1371/journal.ppat.1004434.g009 incubation with Fc receptor blocking reagent (MACS Miltenyi Biotec) for 10 minutes at 4uC, surface staining of pDC markers, CD123 and BDCA-2 and/or the cell differentiation markers CD83 and CD86 were detected by a 40 minute incubation at 4uC with 5 mg/mL of the indicated combinations of PE-conjugated mouse anti-CD123, APC-conjugated anti-BDCA-2, PerCP-conjugated anti-CD83, and APC conjugated anti-CD86, respectively, diluted in staining buffer (PBS without calcium and magnesium, with 2% FBS), followed by PBS washes. Cells were then fixed by incubation for 20 minutes at room temperature with 4% paraformaldehyde, followed by 20 minutes incubation with 0.1 M glycin-PBS at room temperature and two PBS washes. For intracellular-immunostaining of IFNa, cocultivated cells were treated with 1 ml/ml GolgiPlug solution (BD Bioscience) before collection. After fixation and CD123-staining steps, IFNa was detected by a 40 minute incubation with APC-conjugated mouse anti-IFNa (MACS Miltenyi Biotec) diluted at 1:10 in permeabilization buffer (BD Bioscience). Cells were then washed twice with permeabilization buffer and resuspended in staining buffer. Flow cytometric analysis was performed using a Digital LSR II, and the data were analyzed with Flow Jo software (Tree Star). The corresponding control isotypes served to define the specific signal.
Detection of DENV RNA in pDC-infected cell co-cultures by Fluorescent In Situ Hybridization (FISH) analysis
After isolation, 5610 4 pDCs were stained by using 0.5 mM Vibrant cell-labeling solution (CM-DiI, Life Technologies) by successive incubations for 10 and 15 minutes at 37uC and 4uC respectively. Labeled pDCs were washed twice with PBS and then co-cultured with pre-plated DENV infected cells for 5 hours at 37uC in glass bottom 96 well-plate (Fisher Scientific), pretreated with poly-L-lysine at 8 mg/mL. After 4% PFA fixation at room temperature and PBS washing, DENV plus strand RNA was detected using a probe set that targets a region between nucleotide positions 8437-to-9685 in the DENV-2 NGC genome (Panomics/ Affymetrix) according to the manufacturer's instructions. For IFNa immunostaining, the cells were permeabilized by incubation for 7 minutes in PBS containing 0.3% (v/v) Triton -and 3% (w/v) BSA, then incubated with mouse anti-IFNa antibody (MACS Miltenyi Biotec) at 2 mg/ml in PBS containing 3% BSA for 40 minutes at room temperature, followed by an incubation with Alexa 647-conjugated anti-mouse antibody (Life Technologies) and Hoechst dye for 40 minutes at room temperature. As controls, FISH detection of DENV RNA were performed in co-cultures of pDCs with non-infected cells and in co-cultures of pDCs with DENV infected cells by omitting DENV-specific probe and by following the same procedure of hybridization and immunostaining. Images were acquired with a Zeiss LSM 710 laser scanning confocal microscope and analyzed with Image J (http://rsb.info. nih.gov/ij) and IMARIS (Bitplane Inc.) software packages.
Immuno-detection of DENV E and prM surface protein and confocal analysis
After immune-isolation, pDCs were stained with 0.5 mM Vibrant cell-labeling solution (CM-DiI) as above-described. 4-to-5610 4 DiI-labeled pDCs (DiI-pDCs) were co-cultured with 4-to-5610 4 DENV infected Huh7.5.1 cells for 8 hours at 37uC. For analysis of DENV E and prM transfer into pDCs and cell contacts, co-cultures were performed in LabTek II Chamber Slide System (Nunc). After 4% PFA fixation and three PBS washes, cells were permeabilized 7 min with 0.1% Triton in PBS prior immunostaining. For analysis of DENV surface protein clustering at the cell contacts, co-cultures were incubated in a 96-Well Optical-Bottom Plates. After 4% PFA fixation and three PBS washes, immunostainings were performed without permeabilization step, as previously described [71] . After blocking step (PBS 3% BSA) actin filaments were stained with CF488A-conjugated phalloidin (Biotium) at 1.25 U/mL, a-tubulin was stained with mouse anti-a tubulin (DM1A clone, from Sigma) at 1:2000-dilution, DENV E glycoproteins were detected using anti-E antibody (3H5 clone) at 1:500-dilution and anti-PrM antibody (DM-1 clone, Abcam) at 1:50-dilution and IFNa was detected by a mouse anti-IFNa (Miltenyi) at 1:20-dilution. Antibodies were diluted in 3% BSA-PBS and added to the cell for 1 hour incubation at room temperature. After three PBS-washes with PBS, cells were incubated with an Alexa 647-conjugated-anti-mouse antibody (for detection of anti-a-tubulin and anti-E antibodies) or Alexa 488-conjugated-anti-mouse (for detection of anti-PrM antibody) at 1:1000-dilution in 3% BSA-PBS, added to the cells along with Hoechst diluted at 1:500 (Molecular Probes) for 1 hour incubation at room temperature. After three washes with PBS, cells in 96 wells plate were directly observed and cells in Labtek were mounted with mowiol prior observation. Images were acquired with a Zeiss LSM 710 laser scanning confocal microscope and analyzed with Image J (http://rsb.info.nih.gov/ij) and IMARIS (Bitplane Inc.) software packages.
Analysis of intracellular and extracellular RNA levels
RNAs were isolated from cells or supernatants harvested in guanidinium thiocyanate citrate buffer (GTC) by phenol/chloroform extraction procedure as previously [3] . The efficiency of RNA extraction and reverse transcription-real-time quantitative PCR (RT-qPCR) was controlled by the addition of carrier RNAs encoding Xef1a (xenopus transcription factor 1a) in vitro transcripts in supernatants diluted in GTC buffer. DENV RNA and Xef1a and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels were determined by RT-qPCR using an iScript RT kit (Biorad) and a One-Step PCR Master Mix kit for qPCR and analyzed using StepOnePlus Real-Time PCR system (Life Technologies). The sequences of the primers used for the RT-qPCR are described in Table S1 . Extracellular and intracellular DENV RNA levels were normalized for Xef1a and GAPDH RNA levels, respectively.
Analysis of extracellular infectivity
Infectivity titers in supernatants were determined by end-point dilution using Huh 7.5.1 cells. Foci forming unit (ffu) were detected 72 hours after infection by GFP expression for WNV and anti-E glycoprotein specific immunofluorescence for DENV. Briefly, Huh 7.5.1 cells were fixed with 4% PFA and permeabilization by incubation for 7 minutes in PBS containing 0.1% Triton. Cells were then blocked in PBS containing 3% BSA for 15 minutes and incubated for 1 hour with mouse anti-E glycoprotein (clone 3H5) hybridoma supernatant diluted at 1:200 in PBS containing 1% BSA. After 3 washes with PBS, cells were incubated 1 hour with secondary Alexa 555-conjugated anti-mouse antibody (1:1'000-dilution) and Hoechst dye (1:1'000-dilution) in PBS containing 1% BSA. Percentage of E-positive cells and GFP expressing cells was determined using a Zeiss Axiovert 135 microscope.
Analysis of concentrated viral supernatants and cell lysats by western blot
Viral supernatant were filtrated through a 0.45 mm filter (Corning) and concentrated prior to Western blot analysis by ultracentrifugation at 110,0006 g for 2 hours at 4uC using a SW41 rotor. The pellets were re-suspended in PBS. Viral pellets and cell lysates were extracted using lysis buffer (150 mM NaCl 50 mM Tris HCl pH 8, 1% NP40, 0.5% Deoxycholate, 0.1% Sodium dodecyl sulfate) and analyzed by Western blotting using hybridoma supernatant-containing anti-E (4G2) and anti-capsid (6F3) at the dilution of 1:500 and actin at 1 mg/ml followed by secondary horse radish peroxidase-coupled antibodies and chemiluminescence.
Imaging combined with flow cytometry analysis of pDC/ DENV cell conjugates Huh 7.5.1 cells were transduced with retroviral based vector pseudotyped with VSV glycoprotein to stably express GFP, as previously described [72] . Forty-eight hours prior co-culture with pDCs, GFP-expressing Huh 7.5.1 cells were infected at a MOI of 3 using a viral stock of DENV. 10 5 GFP-expressing DENV infected cells were co-cultured with 3610 4 pDCs in low-adherence micro-plate designed for cell harvesting by temperature reduction (Nunc UpCell 96F Microwell Plate from Thermo Scientific) for 5 hours at 37uC in presence, or not, of Latrunculin B and Nocodazole (1 mM), as indicated. After 4% PFA fixation, cocultured cells were harvested by equivalent multi-pipetting at room temperature and washed three times with staining buffer (PBS without calcium and magnesium with 2% FBS). After incubation with Fc receptor blocking reagent (MACS Miltenyi Biotec) for 10 minutes at 4uC, surface staining of a pDC marker, CD123, was detected by a 40 minute incubation at 4uC with 5 mg/mL of APCconjugated mouse anti-CD123, diluted in staining buffer, followed by washes with staining buffer. Co-cultured cells were analyzed by Image Stream X technology (Amnis) at magnification 660 using IDEAS software. The cell population defined as pDC/DENV cell conjugates comprises conjugates of at least one CD123+ cell and at least one cell solely GFP+ cell among the total of APC+ cells, GFP+ cells and conjugates. The cell populations were sorted by using masks (IDEAS software) to eliminate i/the non-specific signals i.e., double positive single cells and ii/cells with background levels for APC signal. Post-cell sorting, the accuracy of the gated cell population in regards to the defined criteria was controlled by a visual inspection of the individual pictures in the gated cells population (i.e., assessment with 90 randomly picked pictures of the population defined as conjugates). The percentages of gated single cells or conjugates with an accurate phenotype according to the defined criteria among the total of examined pictures per category of cell population were: 97% for GFP+ gated population, 99% for APC-CD123+ gated population and 89% for conjugates.
Modulation of prM maturation and detection by ELISA
293T cells, which stably express furin, were generated by transfection using Polyethylenimine and selected using hygromycin (at 5 mg/ml). The decRRVKR-CMK inhibitor (Calbiochem) was used to inhibit the Furin activity in Huh7.5.1 co-cultured with the pDCs, as the indicated concentrations. The levels of prM maturation were analyzed by detection of E and prM by ELISA, as previously described [58] . Briefly serial dilutions of viral supernatants were incubated on anti-E (4G2) antibody coated 96-well plate. Then, E and prM were detected by using a humanized version of 3H5 mAb (hu3H5) and anti-prM, respectively. The prM:E ratios were calculated using the viral supernatant dilution with E detection in the linear range.
Expression of DENV glycoproteins
DENV-2 NGC prM and E genes were cloned under the control of CMV promoter, by amplification from pSVprME [73] using primers ADVprME_Fwd (GATCCCCGGGACCGCCACCAT-GGTGAA) and ADVprME_REV (GATCCCCGGGAGCTT-GATATCAGGCCTGC) and cloned into the Sma I site of the adenovirus shuttle vector pDC104 under the control of the CMV promoter to produce pAdvprME. AdvprME was transfected into cells using the Xtreme-GENE HP DNA Transfection Reagent, follow the manufacturer's instructions. Six hours post-transfection, the cells were washed with PBS and fresh culture medium added to the cells for additional incubation times. At 48 hours posttransfection, the cells were harvested and co-cultured with isolated pDCs for 18-20 hours. Parallel determination of intracellular protein levels by Western blot in harvested cells and their supernatants concentrated by using vivaspin concentrator with centrifugation at 3000 g for 30 min (cut-off 100 KDa, Sartorius). Figure S10 Impact of internalization inhibitors on IFNa production by pDCs co-cultured with DENV infected cells. Impact of inhibitors of clathrin-mediated endocytosis (chlorpromazine, CPZ, at 14 mM), of dynamin-dependent internalization (dynasore, at 100 mM) and macropinocytosis (Gö6983-PKC inhibitor, GO, at 5 mM) on pDC IFNa production triggered by DENV infected cells. (A) Quantification of IFNa in the supernatants of pDCs co-cultured with DENV infected Huh7.5.1 cells (DENV cells) or, as control, stimulated by TLR7 agonist the R848 (50 ng/mL), an imidazoquinoline known as a cellpermeable weak base that passively diffuses inside the pDCs. Results are expressed relative to IFNa produced in absence of inhibitor, set to 100 (means 6 SD, n = 4). Arrows indicate results below the limit of detection of the IFNa ELISA (i.e., 12.5 pg/ml). Quantification of the levels of infectious virus production (B) and intracellular DENV genome equivalent (GE) (C) by Huh7. Figure 7 . Absence of detection of E glycoprotein (E GP, purple) (A) and prM (green) (B) in co-cultures of DiI-stained pDCs (red) with uninfected Huh 7.5.1 cells, analyzed exactly as in Figure 7F -K and 7L-Q, respectively. Left panels, confocal analysis of DENV envelope proteins, E GP (purple), prM (green), DiI-stained pDCs (Red), actin detected by Alexa 488-conjugated phalloidin (green), when indicated, and nuclei (blue). Middle panels, confocal microscopy analysis of DENV envelope proteins and nuclei (blue) projected on the phase contrast imaging. Right panels, confocal microscopy analysis of DENV envelope proteins and nuclei (blue). Star mark 
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